Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ablynx, a Sanofi company
First in human study to collect safety and pharmacokinetics (PK) of single ascending dose in Healthy subjects
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy male and/or female subjects between the ages of 18 and 55 years.
Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight \>50 kg (110 lbs).
You may not be if
Treatment with an investigational drug within 30 days (or as determined by the local requirement, whichever is longer) or 5 half-lives preceding the first dose of study medication.
Receipt or treatment with an investigational or marketed biologic drug.
blood donation of approximately 1 pint (500 mL) within 56 days prior to dosing.
Clareo Health | A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects
